vs
Bank7 Corp.（BSVN）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Bank7 Corp.的季度营收约是STANDARD BIOTOOLS INC.的1.2倍（$24.1M vs $19.6M），Bank7 Corp.净利率更高（44.7% vs -177.4%，领先222.1%），Bank7 Corp.同比增速更快（-0.1% vs -11.5%），Bank7 Corp.自由现金流更多（$41.4M vs $-23.1M），过去两年Bank7 Corp.的营收复合增速更高（0.2% vs -12.2%）
Bank7 Corp是美国的金融控股公司，旗下运营全服务社区银行Bank7，提供商业及个人银行产品，包括存款账户、小微企业贷款、商业地产融资及个人贷款解决方案，核心服务区域覆盖俄克拉荷马州、得克萨斯州、堪萨斯州，客群以中小企业和零售客户为主。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
BSVN vs LAB — 直观对比
营收规模更大
BSVN
是对方的1.2倍
$19.6M
营收增速更快
BSVN
高出11.3%
-11.5%
净利率更高
BSVN
高出222.1%
-177.4%
自由现金流更多
BSVN
多$64.5M
$-23.1M
两年增速更快
BSVN
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $24.1M | $19.6M |
| 净利润 | $10.8M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 58.7% | -168.5% |
| 净利率 | 44.7% | -177.4% |
| 营收同比 | -0.1% | -11.5% |
| 净利润同比 | -2.9% | -28.8% |
| 每股收益（稀释后） | $1.13 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BSVNLAB
| Q4 25 | $24.1M | — | ||
| Q3 25 | $25.2M | $19.6M | ||
| Q2 25 | $24.4M | $21.8M | ||
| Q1 25 | $22.6M | $40.8M | ||
| Q4 24 | $24.1M | — | ||
| Q3 24 | $24.9M | $22.1M | ||
| Q2 24 | $24.4M | $22.5M | ||
| Q1 24 | $24.0M | $45.5M |
净利润BSVNLAB
| Q4 25 | $10.8M | — | ||
| Q3 25 | $10.8M | $-34.7M | ||
| Q2 25 | $11.1M | $-33.5M | ||
| Q1 25 | $10.3M | $-26.0M | ||
| Q4 24 | $11.1M | — | ||
| Q3 24 | $11.8M | $-26.9M | ||
| Q2 24 | $11.5M | $-45.7M | ||
| Q1 24 | $11.3M | $-32.2M |
毛利率BSVNLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率BSVNLAB
| Q4 25 | 58.7% | — | ||
| Q3 25 | 56.2% | -168.5% | ||
| Q2 25 | 60.2% | -118.1% | ||
| Q1 25 | 60.7% | -80.8% | ||
| Q4 24 | 61.0% | — | ||
| Q3 24 | 62.2% | -120.9% | ||
| Q2 24 | 62.5% | -134.5% | ||
| Q1 24 | 62.0% | -132.2% |
净利率BSVNLAB
| Q4 25 | 44.7% | — | ||
| Q3 25 | 43.0% | -177.4% | ||
| Q2 25 | 45.4% | -153.7% | ||
| Q1 25 | 45.7% | -63.8% | ||
| Q4 24 | 46.0% | — | ||
| Q3 24 | 47.3% | -122.0% | ||
| Q2 24 | 47.2% | -203.3% | ||
| Q1 24 | 47.0% | -70.6% |
每股收益（稀释后）BSVNLAB
| Q4 25 | $1.13 | — | ||
| Q3 25 | $1.13 | $-0.09 | ||
| Q2 25 | $1.16 | $-0.09 | ||
| Q1 25 | $1.08 | $-0.07 | ||
| Q4 24 | $1.16 | — | ||
| Q3 24 | $1.24 | $-0.07 | ||
| Q2 24 | $1.23 | $-0.12 | ||
| Q1 24 | $1.21 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $251.0M | $399.7M |
| 总资产 | $2.0B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BSVNLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M |
总债务BSVNLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益BSVNLAB
| Q4 25 | $251.0M | — | ||
| Q3 25 | $241.7M | $399.7M | ||
| Q2 25 | $231.9M | $424.5M | ||
| Q1 25 | $221.7M | $454.6M | ||
| Q4 24 | $213.2M | — | ||
| Q3 24 | $204.2M | $489.3M | ||
| Q2 24 | $190.8M | $510.3M | ||
| Q1 24 | $180.4M | $577.3M |
总资产BSVNLAB
| Q4 25 | $2.0B | — | ||
| Q3 25 | $1.9B | $539.6M | ||
| Q2 25 | $1.8B | $557.0M | ||
| Q1 25 | $1.8B | $579.6M | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.7B | $681.5M | ||
| Q2 24 | $1.7B | $708.7M | ||
| Q1 24 | $1.8B | $777.7M |
负债/权益比BSVNLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.1M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $41.4M | $-23.1M |
| 自由现金流率自由现金流/营收 | 171.7% | -118.1% |
| 资本支出强度资本支出/营收 | 19.7% | 4.5% |
| 现金转化率经营现金流/净利润 | 4.28× | — |
| 过去12个月自由现金流最近4个季度 | $74.8M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流BSVNLAB
| Q4 25 | $46.1M | — | ||
| Q3 25 | $16.6M | $-22.2M | ||
| Q2 25 | $9.4M | $-20.7M | ||
| Q1 25 | $11.0M | $-30.3M | ||
| Q4 24 | $55.0M | — | ||
| Q3 24 | $13.4M | $-27.9M | ||
| Q2 24 | $8.1M | $-39.0M | ||
| Q1 24 | $20.4M | $-62.5M |
自由现金流BSVNLAB
| Q4 25 | $41.4M | — | ||
| Q3 25 | $16.4M | $-23.1M | ||
| Q2 25 | $8.8M | $-22.6M | ||
| Q1 25 | $8.2M | $-35.3M | ||
| Q4 24 | $50.8M | — | ||
| Q3 24 | $12.7M | $-30.1M | ||
| Q2 24 | $6.5M | $-41.0M | ||
| Q1 24 | $19.8M | $-63.3M |
自由现金流率BSVNLAB
| Q4 25 | 171.7% | — | ||
| Q3 25 | 65.0% | -118.1% | ||
| Q2 25 | 36.1% | -103.6% | ||
| Q1 25 | 36.3% | -86.6% | ||
| Q4 24 | 210.6% | — | ||
| Q3 24 | 51.2% | -136.4% | ||
| Q2 24 | 26.8% | -182.2% | ||
| Q1 24 | 82.3% | -138.9% |
资本支出强度BSVNLAB
| Q4 25 | 19.7% | — | ||
| Q3 25 | 0.8% | 4.5% | ||
| Q2 25 | 2.6% | 8.7% | ||
| Q1 25 | 12.4% | 12.4% | ||
| Q4 24 | 17.4% | — | ||
| Q3 24 | 2.5% | 10.2% | ||
| Q2 24 | 6.6% | 8.6% | ||
| Q1 24 | 2.8% | 1.7% |
现金转化率BSVNLAB
| Q4 25 | 4.28× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 0.85× | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 4.96× | — | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 0.71× | — | ||
| Q1 24 | 1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BSVN
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
